Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Научный центр психического здоровья РАМН, Москва
Список исп. литературыСкрыть список 1. Абрамова Л.И., Олейчик И.В., Иванец Н.Н. и др. Ципралекс (эсциталопрам) при лечении тяжелых эндогенных депрессий: особенности терапевтической эффективности и переносимости. Психиатр. и психофармакотер. 2007; 9 (2): 48–53. 2. Артюх В.В. Место антидепрессантов из группы селективных ингибиторов обратного захвата серотонина в терапии юношеских депрессий (клинико-терапевтические корреляции и возрастные особенности). Автореф. дис. … канд. мед. наук. М., 2005. 3. Бородин В.И., Канаева Л.С., Захарова К.В., Миронова Н.В. Клиническая эффективность и переносимость препарата «Ципралекс» (эсциталопрам) при терапии легких и умеренно выраженных депрессий. Психиатр. и психофармакотер. 2005; 5: 287–91. 4. Мосолов С.Н. Клиническая эффективность и переносимость препарата эсциталопрам при лечении умеренной и тяжелой депрессии. Соврем. терапия психических расстройств. 2007; 2. 5. Asarnow JR, Emslie GJ et al. Treatment of SSRI-Resistant Depression in Adolescents (TORDIA): Predictors and moderators of treatment response. J Am Acad of Child and Adoles Psychiat 2009; 48: 330–5. 6. Axelson DA, Perel JM, Birmaher B et al. Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. Am J Psychiat 2005; 162: 802–4. 7. Bailly D. Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents. Pres Med 2006; 35 (9): 1293–1302. 8. Barbui C. Escitalopram versus other antidepressive agents for depression. Cochrane Collaboration. John Wiley & Sons, Ltd. Cochrane Library 2009; Is. 2. http://www.thecochranelibrary.com 9. Birmaher B, Waterman GS, Ryan ND et al. A randomized controlled trial of amitriptyline versus placebo for adolescents with «treatment–resistant» major depression. J Am Acad Child Adoles Psychiat 1998; 37: 527–35. 10. Bremner JD, Smith WT. Org 3770 vs amitriptyline in the continuation treatment of depression: a placebo-controlled trial. Eur J Psychiat 1996; 10: 10. 11. Burke WJ, Gergel I, Bose A. Fixed dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiat 2002; 63: 331–6. 12. Campo JV, Bridge JA. Treatment of Youth Depression. Am J Psychiat 2009; 166: 958–60. 13. Cheung A, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiat 2005; 46 (7): 735–54. 14. Emslie GJ, Ventura D, Korotzer AT et al. Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial. J Am Acad Child Adoles Psychiat 2009; 48: 721–9. 15. Geller B, Reising D, Leonard HL et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad of Child and Adoles Psychiat 1999; 38: 513–6. 16. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectrums 2002; 7: 40–4. 17. Hazell P. Depression in children and adolescents. Clin Evid 2004; 12: 427–42. 18. Hazell P, O\'Connell D, Heathcote D et al. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. BMJ 1995; 310: 897–901. 19. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1994; 9 (1): 19–26. 20. Kairuz T, Truter I, Hugo J et al. Prescribing patterns of tricyclic and selective serotonin reuptake inhibitor antidepressants among a sample of adolescents and young adults. Pharmacoepidemiol and Drug Saf 2003; 12: 379–82. 21. Keller MB. Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials. J Clin Psychiat 2000; 61: 896–908. 22. Kramer AD, Feiguine RJ. Clinical effects of amitriptyline in adolescent depression: a pilot study. J Am Acad Child Psychiat 1981; 20: 636–44. 23. Kye СН, Waterman GS, Ryan ND et al. A randomized, controlled trial of amitriptyline in the Acute Treatment of Adolescent major depression. J Am Acad Child Adoles Psychiat 1996; 35 (9): 1139–44. 24. Lily Y, Scott LJ. Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients. Pediatric Drugs 2010; 12 (3): 155–63. 25. Liu B, Anderson C, Mittman N et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351: 1303–7. 26. Lydiard RB, Stahl SM, Hertzman M, Harrison WM. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J Clin Psychiat 1997; 58 (11): 484–91. 27. Marcelli D. Depression de l\'adolescent. Perspect Psy 1998; 37 (4): 241–8. 28. Michael KD, Crowley SL. How effective are treatments for child and adolescent depression? A meta-analytic review. Clin Psychol Rev 2002; 22 (2): 247–69. 29. Rao U, Chen LA. Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialog Clin Neuros 2009; 11: 45–62. 30. Wagner KD. Pharmacotherapy for major depression in children and adolescents. Prog Neuropsychopharmacol Biol Psychiat 2005; 29: 819–26. 31. Whittington CJ, Kendall T, Pilling S. Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Curr Opin Psychiat 2005; 18: 21–5.